相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Proteasome inhibition promotes regression of left ventricular hypertrophy
William E. Stansfield et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Proteasome inhibition decreases cardiac remodeling after initiation of pressure overload
Nadia Hedhli et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Proteasome inhibition 1 h following ischemia protects GRK2 and prevents malignant ventricular tachyarrhythmias and SCD in a model of myocardial infarction
Shijun Huang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Overexpression of endoplasmic reticulum-resident chaperone attenuates cardiomyocyte death induced by proteasome inhibition
Hai Ying Fu et al.
CARDIOVASCULAR RESEARCH (2008)
Proteasome inhibitors in cancer therapy: Lessons from the first decade
Robert Z. Orlowski et al.
CLINICAL CANCER RESEARCH (2008)
Suppression of cardiomyocyte hypertrophy by inhibition of the ubiquitin-proteasome system
Silke Meiners et al.
HYPERTENSION (2008)
Upregulation of myocardial 11 S-activated proteasome in experimental hyperglycemia
Saul R. Powell et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)
Proteasome inhibitors: Poison's and remedies
Silke Meiners et al.
MEDICINAL RESEARCH REVIEWS (2008)
Two-dimensional electrophoresis-based characterization of post-translational modifications of mammalian 20S proteasome complexes
Chenggong Zong et al.
PROTEOMICS (2008)
Understanding proteasome assembly and regulation: Importance to cardiovascular medicine
Glen W. Young et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2008)
Role of proteasomes in disease
Burkhardt Dahlmann
BMC BIOCHEMISTRY (2007)
Mammalian proteasome subpopulations with distinct molecular compositions and proteolytic activities
Oliver Drews et al.
MOLECULAR & CELLULAR PROTEOMICS (2007)
Chronic proteasome inhibition contributes to coronary atherosclerosis
Joerg Herrmann et al.
CIRCULATION RESEARCH (2007)
Intermediate-type 20 S proteasomes in HeLa cells: Asymmetric subunit composition, diversity and adaptation
Nicola Klare et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Proteasome inhibitor, bortezomib, for myeloma and lymphoma
Kensei Tobinai
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2007)
Unexpected cardiotoxicity in haematological bortezomib treated patients
Enrico Orciuolo et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Proteasome inhibitors: antitumor effects and beyond
A. Nencioni et al.
LEUKEMIA (2007)
Circulating proteasomes, are functional and have a subtype pattern distinct from 20S proteasomes in major blood cells
Annette Zoeger et al.
CLINICAL CHEMISTRY (2006)
Activation of the cardiac proteasome during pressure overload promotes ventricular hypertrophy
Christophe Depre et al.
CIRCULATION (2006)
Comprehensive quantitative proteome analysis of 20S proteasome subtypes from rat liver by isotope coded affinity tag and 2-D gel-based approaches
Frank Schmidt et al.
PROTEOMICS (2006)
The ubiquitin-proteasome system in cardiac physiology and pathology
Saul R. Powell
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Nontoxic proteasorne inhibition activates a protective antioxidant defense response in endothelial cells
Silke Meiners et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Comparative selectivity and specificity of the proteasome inhibitors BzLLLCOCHO, PS-341, and MG-132
Lisa J. A. Crawford et al.
CANCER RESEARCH (2006)
Severe reversible cardiac failure after bortezomib treatment combined with chemotherapy in a non-small cell lung cancer patient: a case report
Jens Voortman et al.
BMC CANCER (2006)
Importance of the different proteolytic sites of the proteasome and the efficacy of inhibitors varies with the protein substrate
AF Kisselev et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Depression of proteasome activities during the progression of cardiac dysfunction in pressure-overloaded heart of mice
O Tsukamoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Proteasome mediates removal of proteins oxidized during myocardial ischemia
A Divald et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Proteasome inhibition: Novel therapy for multiple myeloma
JL Kaufman et al.
ONKOLOGIE (2006)
Inhibition of NF-κB induces regression of cardiac hypertrophy, independent of blood pressure control, in spontaneously hypertensive rats
S Gupta et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Activity probe for in vivo profiling of the specificity of proteasome inhibitor bortezomib
CR Berkers et al.
NATURE METHODS (2005)
Oxidized and ubiquitinated proteins may predict recovery of postischemic cardiac function: Essential role of the proteasome
SR Powell et al.
ANTIOXIDANTS & REDOX SIGNALING (2005)
Molecular machines for protein degradation
M Groll et al.
CHEMBIOCHEM (2005)
Long-term up-regulation of eNOS and improvement of endothelial function by inhibition of the ubiquitin-proteasome pathway
V Stangl et al.
FASEB JOURNAL (2004)
The proteasome: a proteolytic nanomachine of cell regulation and waste disposal
DH Wolf et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2004)
Phase I trial of the proteasome inhibitor bortezomib in patients with advanced solid tumors with observations in androgen-independent prostate cancer
CN Papandreou et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
NF-κB activation is required for the development of cardiac hypertrophy in vivo
YH Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Clinical update: proteasome inhibitors in solid tumors
HJ Lenz
CANCER TREATMENT REVIEWS (2003)
Proteasome inhibition ablates activation of NF-κB in myocardial reperfusion and reduces reperfusion injury
J Pye et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
β2 subunit propeptides influence cooperative proteasome assembly
M De et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Preclinical and clinical evaluation of proteasome inhibitor PS-341 for the treatment of cancer
J Adams
CURRENT OPINION IN CHEMICAL BIOLOGY (2002)
A proteasome inhibitor confers cardioprotection
H Lüss et al.
CARDIOVASCULAR RESEARCH (2002)
Proteasome inhibitors: from research tools to drug candidates
AF Kisselev et al.
CHEMISTRY & BIOLOGY (2001)
Different proteasome subtypes in a single tissue exhibit different enzymatic properties
B Dahlmann et al.
JOURNAL OF MOLECULAR BIOLOGY (2000)
分享论文
